Disease Modifying Therapies

As we have talked about everyone MS is not the same. However, DMTs could be a helpful component in your MS care. Keep in mind, DMTs don’t treat symptoms of MS, but they may reduce the number of relapses and slow the progression of physical disability.

Even if you may not be experiencing MS symptoms regularly, your MS may still be progressing. It’s important to work with your doctor to discuss a treatment option that meets your need sooner than later….

Explore Disease Modifying Treatments for MS 
  • Alemtuzumab (Lemtrada)
  • Avonex (Interferon beta-1a)
  • Betaferon (Interferon beta-1b)
  • Cladribine (Mavenclad)
  • Dimethyl fumarate (Tecfidera)
  • Extavia (beta interferon-1b) 
  • Fingolimod (Gilenya)
  • Glatiramer acetate (Copaxone)
  • HSCT
  • Natalizumab (Tysabri)
  • Ocrelizumab (Ocrevus)
  • Plegridy (peginterferon beta-1a)
  • Rebif (beta interferon-1a)
  • Siponimon (Mayzen)
  • Teriflunomide (Aubagio)
To learn more click on the ribbon…
Contact Me!
https://www.googletagmanager.com/gtag/js?id=UA-176057055-1 window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-176057055-1');
!function(e){if(!window.pintrk){window.pintrk = function () { window.pintrk.queue.push(Array.prototype.slice.call(arguments))};var n=window.pintrk;n.queue=[],n.version="3.0";var t=document.createElement("script");t.async=!0,t.src=e;var r=document.getElementsByTagName("script")[0]; r.parentNode.insertBefore(t,r)}}("https://s.pinimg.com/ct/core.js"); pintrk('load', '2612380431501', {em: ''}); pintrk('page'); <img height="1" width="1" style="display:none;" alt="" src="https://ct.pinterest.com/v3/?event=init&tid=2612380431501&pd%5Bem%5D=&noscript=1" />

Published by

TheGirlWithaPlan

I am 27 years old, this blog is about my journey with Multiple Sclerosis (MS) from the time I got the news when I was 19 until now. I have enjoyed writing it and I hope you enjoy reading it.

One thought on “Disease Modifying Therapies

Leave a Reply

Your email address will not be published. Required fields are marked *